Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04802187 · ClinicalTrials.gov registry record · NA

Implementation of COVID-19 Testing Strategies in Community Health Centers

A NA study of Covid19, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
6
Enrollment target
2
Study locations

NCT04802187 is a NA study of Covid19 that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04802187, a NA study of Covid19, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
2
Study locations

Study Summary

This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.

Conditions Studied

Interventions

  • OTHER RADx CHCs testing intervention strategy
  • OTHER Usual care control

Study Locations (2)

Massachusetts

  • Massachusetts League of Community Health Centers - Boston
  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-12-01
Est. Completion 2022-07-15
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04802187

The ClinicalTrials.gov registry entry for NCT04802187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 2 interventions - of which RADx CHCs testing intervention strategy is the first listed.

NCT04802187 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04802187 about?

NCT04802187 is a clinical study titled "Implementation of COVID-19 Testing Strategies in Community Health Centers". This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implement...

What is the current status of trial NCT04802187?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-12-01. Estimated completion is 2022-07-15.

What conditions does trial NCT04802187 study?

This clinical trial studies the following conditions: Covid19.

What interventions are being tested in trial NCT04802187?

The interventions under investigation include: RADx CHCs testing intervention strategy (OTHER), Usual care control (OTHER).

Who is sponsoring clinical trial NCT04802187?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04802187 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.